GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
603127 Joinn Laboratories
- 15.69
- +0.20+1.29%
Market Closed Jan 24 15:00 CST
11.76BMarket Cap-15690.00P/E (TTM)
15.79High15.37Low49.95KlotVolume15.49Open15.49Pre Close78.08MTurnover0.79%Turnover Ratio29.60P/E (Static)749.48MShares21.7452wk High1.47P/B9.89BFloat Cap12.1652wk Low17.04Limit Up630.48MShs Float92.24Historical High13.94Limit Down2.71%Amplitude1.45Historical Low0.16Dividend TTM15.63Avg Price23.93KlotAsk1.02%Div YieldTTM100Lot Size24.25KlotBid
Joinn Laboratories News
Beijing Zhaoyan New Drug Research Center Co., Ltd. 2024 Annual Results Forecast
Zhaoyan Pharmaceutical: Announcement of Resolutions of the 12th Meeting of the 4th Board of Directors of Beijing Zhaoyan New Drug Research Center Co., Ltd.
Zhaoyan Pharmaceutical: Announcement of Resolutions of the 12th Meeting of the 4th Board of Directors of Beijing Zhaoyan New Drug Research Center Co., Ltd.
Zhaoyan Pharmaceutical: Announcement of Resolutions of Zhaoyan Pharmaceutical\'s 2025 First Extraordinary General Meeting of Shareholders, 2025 First Class A Shareholders\' Meeting, and 2025 First H Share Class Shareholders\' Meeting
Zhaoyan New Pharmaceutical: Legal Opinions of Beijing Tianyuan Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Zhaoyan New Pharmaceutical, the First Class A Shareholders\' Meeting in 2025, and the First Class H Shareholders\' Meeting in 2025
Announcement of Resolutions of the 12th Meeting of the 4th Board of Directors of Beijing Zhaoyan New Drug Research Center Co., Ltd.
Legal Opinions of Beijing Tianyuan Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Zhaoyan New Pharmaceutical, the First Class A Shareholders\' Meeting in 2025, and the First Class H Shareholders\' Meeting in 2025
Announcement of Resolutions of the 12th Meeting of the 4th Board of Directors of Beijing Zhaoyan New Drug Research Center Co., Ltd.
Announcement of Resolutions of Zhaoyan Pharmaceutical\'s 2025 First Extraordinary General Meeting of Shareholders, 2025 First Class A Shareholders\' Meeting, and 2025 First Class H Shareholders\' Meeting
Zhaoyan Pharmaceutical\'s announcement on the progress of repurchasing the company\'s A-share shares through centralized bidding transactions
Notice of Zhaoyan Pharmaceutical on holding the first extraordinary general meeting of shareholders in 2025, the first A-share shareholders\' meeting in 2025, and the first H-share shareholders\' meeting in 2025
H share announcement
H Shares Announcement: Next Day Disclosure Statement
Information on the 2025 First Extraordinary General Meeting of Shareholders of Zhaoyan Pharmaceutical, the first Class A Shareholders\' Meeting in 2025, and the First Class H Shareholders\' Meeting in 2025
H share announcement
Zhaoyan New Pharmaceutical: H share announcement
H share announcement
Zhaoyan New Pharmaceutical: H share announcement
H share announcement
H Shares Announcement: Proposed Further Changes to the Use of Net Proceeds